Zephyr Valve Procedure Offers a Breath of Relief
Ray Freeman used to get so short of breath that he had to stop and lean against his car before he could finish walking down his driveway to reach his mailbox.
Diagnosed with asthma in 2010, he was periodically prescribed antibiotics for infections and prednisone for lung inflammation. His breathing kept getting worse.
He was hospitalized for nine days with a lung infection in 2012 and spent three weeks in intensive care with pneumonia three years later. That’s when he met a pulmonologist who determined that Freeman had emphysema, not asthma.
Emphysema is a progressive disease that destroys the tiny air sacs in the lungs. The damage can trap air, reduce the lung’s ability to transfer oxygen into the bloodstream and make everyday tasks difficult.
Having emphysema feels “like somebody puts a plastic bag over your head, ties it around your neck and they put a little pinhole in it for you to breathe,” Freeman said. “It felt like torture.”
In December 2023, Freeman saw his pulmonologist for his regular six-month checkup and asked whether there was any new treatment. “I can’t keep living like this,” he told the doctor.
Freeman was referred to Dr. Melhem Imad at Chesapeake Regional Healthcare to be evaluated for treatment with the Zephyr endobronchial valve system.
Imad has been performing the Zephyr valve procedure since shortly after its FDA approval in 2018 and has helped other physicians establish programs in the area.
“Dr. Imad just explained every single thing to me the whole way,” Freeman said. “He was very, very helpful.”
“People often assume that bigger lungs would make breathing easier, but with emphysema, the opposite happens,” Imad explained. “As air becomes trapped, the lungs become overinflated. Some parts expand more than others, crowding the healthier areas and pushing down on the diaphragm, the main muscle used for breathing. Patients find it hard to exhale fully before they have to take their next breath.”
“That’s where the valves can help. They allow trapped air to leave a carefully selected, severely damaged lobe while preventing new air from entering. As that lobe gradually deflates, it creates more room for the healthier parts of the lung and allows the diaphragm to move more effectively.”
The valves are placed through a bronchoscope, a thin, flexible tube passed through the mouth into the airways, without surgical incisions. Testing beforehand helps determine whether a patient’s lung function and pattern of emphysema make the treatment appropriate.
Before the procedure, Freeman couldn’t walk more than 100 yards without resting. When he went to 7-Eleven for coffee, he was out of breath by the time he reached the back of the store. To avoid concerned questions from strangers, he would pull out his phone and pretend he had stopped to scroll.
At a laundromat, another customer who happened to be a nurse noticed him struggling to breathe while folding clothes and offered to carry his laundry to his car.
Once, he was staying in a hotel on a work trip when he got up in the middle of the night, struggling to breathe. He had to sit on the edge of the bed for over an hour before he could get enough air to walk to the nightstand and get his rescue inhaler.
Freeman, 74, of Virginia Beach, has been a private investigator for insurance companies for about 45 years. The work allows him to spend much of the day seated in a vehicle, which helped him manage even as his breathing worsened.
After months of testing, Freeman underwent the roughly 30-minute procedure in September 2024. Imad used a bronchoscope inserted through the throat to place three valves.
About a month later, Freeman noticed he was improving. He could walk to the mailbox without stopping. The 14 steps from the first to the second floor of his home became easier.
“My life has just changed,” Freeman said. “I can walk around my block now. Remember, I couldn’t walk to the mailbox. It’s three-quarters of a mile around my block.”
Today, Freeman is doing so well that he’s thinking about trying pickleball.
Things to Know:
- Careful evaluation matters. Zephyr valves may help selected patients with severe emphysema who continue to experience significant breathing limitations despite medical treatment. Lung function tests, a CT scan and other assessments help determine whether the treatment is appropriate.
- Understand the benefits and risks. Treatment may improve breathing, activity and quality of life, but results vary. Potential complications include pneumothorax (a collapsed lung), worsening COPD symptoms, infection and, rarely, death. Because pneumothorax is most likely to occur during the first few days, patients stay in the hospital for at least three nights for monitoring.
- Insurance coverage is available. Medicare and many commercial insurance plans cover treatment for eligible patients. Requirements vary, and prior authorization may be necessary. A dedicated team helps patients navigate the coverage and approval process.
To find out whether Zephyr valves may be appropriate for you, speak with your pulmonologist or request a consultation with Dr. Imad at Chesapeake Regional Healthcare or call Lung Health at 757-312-3012.
Visit www.mylungvalves.com to watch Dr. Imad’s educational video and learn more about the procedure.
Dr. Melhem Imad is the only pulmonologist performing the Zephyr endobronchial valve insertion procedure in the area. He is also the first AABIP board-certified Interventional Pulmonologist in Hampton Roads and northeastern North Carolina. He earned his Interventional Pulmonology subspecialty degree at Johns Hopkins University in Baltimore, Md. and is board certified in pulmonary and critical care medicine. Dr. Imad practices with Chesapeake Regional Pulmonology in Chesapeake.